News
Important Only
Rocket Doctor Ai Announces Listed Issuer Financing Exemption (Life) Non-Brokered Private Placement
Jan 9 (Reuters) - Rocket Doctor AI Inc AIDR.CD:ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENTROCKET DOCTOR AI INC - ANNOUNCES PRIVATE PLACEMENT OF 4,285,715 UNITSROCKET DOCTOR AI INC - PRICE PER UNIT SET AT $0.70 FOR $3 MILLION PROCEEDSReuters
Fri, Jan 9
Altus Group Ltd Announces Preliminary Results Of Substantial Issuer Bid
Jan 9 (Reuters) - Altus Group Ltd AIF.TO:ALTUS GROUP LTD - ANNOUNCES PRELIMINARY RESULTS OF SUBSTANTIAL ISSUER BIDALTUS GROUP LTD - TO PURCHASE 2,849,643 SHARES AT C$57.00 EACHALTUS GROUP LTD - AGGREGATE PURCHASE PRICE ABOUT C$162.43 MILLIONReuters
Fri, Jan 9
Madrigal Expands Its Mash Pipeline With Exclusive Global License Agreement For Ervogastat
Jan 9 (Reuters) - Madrigal Pharmaceuticals Inc MDGL.O:MADRIGAL EXPANDS ITS MASH PIPELINE WITH EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR ERVOGASTAT, A PHASE 2 ORAL DGAT-2 INHIBITORMADRIGAL PHARMACEUTICALS INC - PFIZER RECEIVES $50 MILLION UPFRONT PAYMENT FROM MADRIGALMADRIGAL PHARMACEUTICALS INC - PLANS...Reuters
Fri, Jan 9
Orca Bio Announces $250 Million In Aggregate Financing
Jan 9 (Reuters) - ORCA BIO ANNOUNCES $250M IN AGGREGATE FINANCING IN PREPARATION FOR POTENTIAL COMMERCIALIZATIONORCA BIO - COMPLETION OF A SERIES F FINANCING ROUND IN DECEMBER 2025 LED BY LIGHTSPEED VENTURE PARTNERSFurther company coverage: [ ]Reuters
Fri, Jan 9
US quits global organisation dedicated to preventing violent extremism
GCERF highlights increased extremist violence risk in Sahel and AfghanistanContinuing prevention work despite Trump administration's withdrawalGlobal Terrorism Index shows increase in countries experiencing attacksBy Olivia Le Poidevin GENEVA, Jan 9 (Reuters) - A global organisation dedicated...Reuters
Fri, Jan 9
Airnexis Therapeutics Raises $200 Million Series A
Jan 9 (Reuters) - AIRNEXIS THERAPEUTICS LAUNCHES WITH $200M SERIES A TO ADVANCE PHASE 2 DUAL PDE3/4 INHIBITOR AN01 FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)AIRNEXIS THERAPEUTICS: OVER-SUBSCRIBED SERIES A WAS LED BY FRAZIER LIFE SCIENCESFurther company coverage: [ ]Reuters
Fri, Jan 9
Revvity Collaborates With Lilly To Expand Access To Ai Drug Discovery Models
Jan 9 (Reuters) - Revvity Inc RVTY.N:REVVITY COLLABORATES WITH LILLY TO EXPAND ACCESS TO AI DRUG DISCOVERY MODELSREVVITY COLLABORATES WITH LILLY TO EXPAND ACCESS TO AI DRUG DISCOVERY MODELSREVVITY INC: COLLABORATION FUNDS PARTICIPATING BIOTECHS TO ACCESS LILLY PREDICTIVE MODELS THROUGH REVVITY SIGNA...Reuters
Fri, Jan 9
Koppers Announces Retirement Of Chief Financial Officer Jimmi Sue Smith
Jan 9 (Reuters) - Koppers Holdings Inc KOP.N:KOPPERS ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER JIMMI SUE SMITHKOPPERS HOLDINGS INC - BRADLEY PEARCE ELECTED AS INTERIM CFO AND CHIEF ACCOUNTING OFFICERKOPPERS HOLDINGS INC - JIMMI SUE SMITH TO CONTINUE AS TREASURER UNTIL FEBRUARY 28, 2026Reuters
Fri, Jan 9
Oncoclinicas says its CEO succession talks at advanced stage
SAO PAULO, Jan 9 (Reuters) - Brazilian healthcare firm Oncoclinicas ONCO3.SA said on Friday it was at an advanced stage in the process of selecting a new chief executive, but did not give any details of potential candidates.The company was responding to a report published on Thursday by news outlet ...Reuters
Fri, Jan 9
DeepSeek to launch new AI model focused on coding in February, The Information reports
Jan 9 (Reuters) - Chinese AI startup DeepSeek is expected to launch its next-generation AI model V4 that features strong coding capabilities in February, The Information reported on Friday, citing people familiar with the matter. Reuters could not immediately verify the report.Reuters
Fri, Jan 9
Bragg Gaming Further Extends Pam Agreement With Entain
Jan 9 (Reuters) - Bragg Gaming Group Inc BRAG.TO:BRAGG GAMING FURTHER EXTENDS PAM AGREEMENT WITH ENTAINBRAGG GAMING GROUP INC - BETCITY.NL TO USE BRAGG'S PAM PLATFORM UNTIL MAY 2026BRAGG GAMING GROUP INC - EXPECTED TO MATERIALLY CONTRIBUTE TO REVENUESReuters
Fri, Jan 9
Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter Results
Jan 9 (Reuters) - Rhythm Pharmaceuticals Inc RYTM.O:RHYTHM PHARMACEUTICALS ANNOUNCES PRELIMINARY, UNAUDITED FOURTH QUARTER AND FULL YEAR 2025 NET PRODUCT REVENUES AND UPCOMING MILESTONESRHYTHM PHARMACEUTICALS INC - MARCH 20, 2026 PDUFA GOAL DATE FOR SNDA FOR SETMELANOTIDE IN ACQUIRED HYPOTHALAMIC OB...Reuters
Fri, Jan 9
